Protocol Review and Monitoring Committee

The membership of the Protocol Review and Monitoring Committee (PRMC) has been designed to provide broad representation from the various oncology subspecialties, including community oncology, and support areas critical to the success of a clinical research enterprise. This broad representation is necessary to provide high quality and thorough protocol review. All members of the PRMC are full voting members. The Co-Directors of the Cancer Center are ex officio members. The committee meets monthly. See a detailed schedule of committee meeting dates.

Name/EmailTitle/Area of ExpertisePhoneInformation
Michael Lewis, M.D.
Protocol Review and Monitoring Committee Chair;
Associate Professor
(802) 847-3015 Bio
Christopher Anker, M.D.

PRMC Vice Chair:

Assistant Professor
Radiation Oncology

(802) 847- 3506 
Steven Ades, M.D.Associate Professor
Medical Oncology 
(802) 656-5451 Bio
George Atweh, M.D.
Hematology Oncology
(802) 847-8400

Rob Cade, Pharm.D.
Oncology Pharmacist(802) 847-5577
Mark Evans, Ph.D.

Assistant Professor
(802) 656-3628 
Edmund Folefac, M.D.

Assistant Professor
Hematology Oncology
(802) 656-5487 Bio
Alan Howe, Ph.D.
(802) 656-9521
Shelly Naud, Ph.D.
Researcher Analyst
(802) 656-3822 
Scott Perrapato, D.O.
Associate Professor
(802) 847-2884Bio
Karen Wilson, C.C.R.P.
Clinical Trials Supervisor, UVM Cancer Center(802) 656-4101 

Clinical Research Oversight Committee

The Clinical Research Oversight Committee (CROC) was a senior leadership committee charged with the responsibility for Data and Safety Monitoring. All clinical trials require monitoring, which is performed on a regular basis and is commensurate with the risk and size of the trial. The committee met quarterly. The CROC will be replaced with a Data Safety and Monitoring Committee and will be announced mid-2016.